Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Rubius Therapeutics Inc.

    NASDAQ: RUBY · Real-Time Price · USD
    0.06
    0.00 (8.11%)
    At close: Dec 29, 2023, 9:49 PM

    Rubius Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Cash & Equivalents
    		 14.87M 103.88M 62.21M 98.1M 225.85M 264.02M 283.23M 288.09M
    Short-Term Investments
    		 4.07M n/a 78.5M 78.41M n/a n/a 15.01M 42.56M
    Long-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Other Long-Term Assets
    		 50K 1.57M 1.57M 1.57M 1.57M 1.57M 1.57M 1.57M
    Receivables
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Other Current Assets
    		 1.26M 6.94M 81.28M 81.94M 3.98M 6.45M 21.05M 48.17M
    Total Current Assets
    		 20.2M 110.82M 143.49M 180.04M 229.82M 270.47M 304.29M 336.26M
    Property-Plant & Equipment
    		 2.83M 58.3M 84.02M 85.51M 86.63M 89.02M 90.22M 92.4M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Total Long-Term Assets
    		 2.88M 59.87M 85.59M 87.08M 88.2M 90.6M 91.8M 93.97M
    Total Assets
    		 23.07M 170.7M 229.08M 267.12M 318.02M 361.06M 396.08M 430.23M
    Account Payables
    		 1.23M 8.72M 12.44M 12.08M 11.57M 8.49M 5.18M 4.81M
    Deferred Revenue
    		 n/a n/a n/a n/a 13.4M 12.76M 10.38M 7.04M
    Short-Term Debt
    		 1.1M 9.21M 9.15M 9.08M 9.02M 8.82M 8.84M 18.27M
    Other Current Liabilities
    		 5.61M 14.7M 9.41M 7.75M 14.07M 13.62M 11.08M 7.59M
    Total Current Liabilities
    		 7.94M 32.62M 30.99M 28.92M 34.66M 30.93M 25.1M 30.67M
    Long-Term Debt
    		 n/a 101.49M 102.48M 103.45M 104.44M 105.34M 106.25M 97.92M
    Other Long-Term Liabilities
    		 n/a n/a 67K 101K 135K 586K 620K 654K
    Total Long-Term Liabilities
    		 n/a 101.49M 102.55M 103.56M 104.58M 105.92M 106.87M 98.58M
    Total Liabilities
    		 7.94M 134.11M 133.54M 132.47M 139.24M 136.86M 131.97M 129.25M
    Total Debt
    		 1.1M 110.7M 111.63M 112.54M 113.46M 114.16M 115.09M 116.2M
    Book Value
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Book Value Per Share
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Common Stock
    		 90K 90K 90K 90K 90K 90K 90K 89K
    Retained Earnings
    		 -856.68M -836.54M -773.67M -729.43M -677.02M -622M -572.98M -522.8M
    Comprehensive Income
    		 n/a n/a -122K -57K n/a n/a 1K 7K
    Shareholders Equity
    		 15.13M 36.59M 95.54M 134.65M 178.78M 224.21M 264.11M 300.98M
    Total Investments
    		 4.07M n/a 78.5M 78.41M n/a n/a 15.01M 42.56M

    Add to Watchlist